Benzinga
Benzinga
Benzinga
martedì, settembre 29

Oscar Health Inc

OSCRNYSE
Trade with Public
Trade with Public
$29.65
0.050.17%
In chiusura: Sep 28, 5:00 PM EST
$29.71
0.060.2%
Post-mercato: 7:58 PM EST
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

Oscar Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Oscar Health (OSCR).

Price Target Range — 12 Quarters

Analyst Consensus — 8 Analysts

3Buy
4Hold
1Sell
Consensus RatingNeutral# Analysts8Avg. Consensus PT$28Upside to Avg. PT-5.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →
DateFirmAnalystActionRating ChangePrice Target
Sep 18, 2026Raymond JamesJohn RansomPT RaiseOutperform$34→$42
Sep 17, 2026B of A SecuritiesAdam RonPT RaiseUnderperform$28→$30
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Raymond James Maintains Outperform on Oscar Health, Raises Price Target to $42

Raymond James analyst John Ransom maintains Oscar Health (NYSE:OSCR) with a Outperform and raises the price target from $34 to $42.
Benzinga Newsdesk

PRO
B of A Securities Maintains Underperform on Oscar Health, Raises Price Target to $30

B of A Securities analyst Adam Ron maintains Oscar Health (NYSE:OSCR) with a Underperform and raises the price target from $28 to $30.
Benzinga Newsdesk

PRO
Stephens & Co. Reiterates Equal-Weight on Oscar Health, Maintains $34 Price Target

Stephens & Co. analyst Raj Kumar reiterates Oscar Health (NYSE:OSCR) with a Equal-Weight and maintains $34 price target.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Oscar Health, Raises Price Target to $49

Barclays analyst Andrew Mok maintains Oscar Health (NYSE:OSCR) with a Overweight and raises the price target from $39 to $49.
Benzinga Newsdesk

PRO
Baird Maintains Neutral on Oscar Health, Raises Price Target to $33

Baird analyst Michael Ha maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price target from $27 to $33.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on Oscar Health, Raises Price Target to $27

Wells Fargo analyst Stephen Baxter maintains Oscar Health (NYSE:OSCR) with a Equal-Weight and raises the price target from $20 to $27.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved